Vaccine response in patients with weak immune systems
Part of Immune system & allergy clinical trials.
This study looks at how well vaccines for respiratory viruses work in people with weakened immune systems. It may help doctors give better vaccine advice to patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your immune system is weakened either by a medicine you take or by an illness you have
- You have already received or are willing to get recommended vaccines for respiratory viruses
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry to track how people with weakened immune systems respond to vaccines. It helps doctors better understand which vaccines work best for patients like you.
This study looks at how the nose's immune system responds to common respiratory viruses in both healthy people and those with weakened immune systems. It aims to understand how long these responses last.
This study tests how well a rabies vaccine works and how safe it is for people whose immune systems may be weaker, such as those with certain long-term illnesses, organ transplants, or age 60 and older. It compares them to healthy adults ages 18 to 59.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This study looks at how well a COVID-19 booster works in adults who need long-term medicines that lower immune response. It aims to see whether immunosuppressed people benefit from booster vaccination safely.
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
Hear when a new Immunodeficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.